| Line item | 2025-09-30 FY | 2024-09-30 FY | 2023-09-30 FY | 2022-09-30 FY | 2021-09-30 FY |
|---|---|---|---|---|---|
| Revenue | $12.04B | $12.10B | $12.60B | $12.70B | $10.32B |
| Cost of Revenue | $8.26B | $8.17B | $8.83B | $9.34B | $7.19B |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $96.30M | $100.20M | $105.60M | $102.90M | $93.50M |
| SG&A | $906.10M | $942.40M | $957.00M | $900.60M | $828.40M |
| Operating Income | -$877.00M | $4.47B | $2.49B | $2.34B | $2.28B |
| Interest Expense | – | – | $177.50M | $128.00M | $141.80M |
| Tax Expense | -$94.30M | $944.90M | $551.20M | $500.80M | $462.80M |
| Net Income | -$394.50M | $3.83B | $2.30B | $2.26B | $2.10B |
| EPS (basic) | -1.7700 | 17.2100 | 10.3500 | 10.1600 | 9.4700 |
| EPS (diluted) | -1.7700 | 17.1800 | 10.3300 | 10.1400 | 9.4300 |
| Shares (diluted) | $222.70M | $222.80M | $222.70M | $222.50M | $222.50M |